DUBLIN--(BUSINESS WIRE)--The "Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay, Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global neuroscience antibodies and assays market is expected to reach USD 4.18 billion by 2023 from USD 2.57 billion in 2018, at a CAGR of 10.2%
Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. On the other hand, quality and cost concerns over the production of antibodies is the major factor restraining the growth of this market.
Based on product, the neuroscience antibodies and assays market is segmented into consumables and instruments. The consumables segment is expected to register the highest CAGR during the forecast period. The consistent usage of consumables and their frequent purchases, and rising government initiatives in the genomics and proteomics research sector are the major factors supporting the growth of the consumables segment.
Based on end user, the neuroscience antibodies and assays market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic centers. The pharmaceutical and biotechnology companies segment is expected to account for the largest share of the neuroscience antibodies and assays market in 2018. The large share of this segment can be attributed to the high uptake of neuroscience antibodies in the drug discovery and development process and rising government initiatives in the genomics and proteomics research sectors.
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in the Asian market is attributed to factors such as growing research on proteomics and genomics, favorable funding scenario, and rising incidence of neurological diseases in the Asian region.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Neuroscience Antibodies and Assays Market, By Product
7 Neuroscience Antibodies and Assays Market, By Technology
8 Neuroscience Antibodies and Assays Market, By Application
9 Neuroscience Antibodies and Assays Market, By End User
10 Neuroscience Antibodies and Assays Market, By Region
11 Competitive Landscape
12 Company Profiles
- Thermo Fisher Scientific
- Merck KGaA
- Cell Signaling Technology
- Rockland Immunochemicals
- Santa Cruz Biotechnology
- F. Hoffmann-La Roche
For more information about this report visit https://www.researchandmarkets.com/research/j3jg7r/neuroscience?w=4